Showing results (51-60 of 125) with videos related to
Sort By:
Pageof 13
Biochemical Pharmacology|October 15, 1985
Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovaryH D Su, G J Mazzei, W R Vogler, et al.Cancer Investigation|December 9, 1998
The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivoW R Vogler, J Liu, O Volpert, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Inhibition of induced angiogenesis in a human microvascular endothelial cell line by ET-18-OCH3F J Candal, D C Bosse, W R Vogler, et al.Experimental Hematology|January 1, 1994
Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell linesM Shoji, T Fukuhara, E F Winton, et al.Biochemical and Biophysical Research Communications|December 30, 1988
Inhibition of Na,K-ATPase and sodium pump by anticancer ether lipids and protein kinase C inhibitors ET-18-OCH3 and BM 41.440K Oishi, B Zheng, J F White, et al.Cancer|January 15, 1981
Marrow cell kinetics in patients treated with methotrexate and citrovorum factorW R Vogler, Z H Israili, A G Soliman, et al.American Journal of Clinical Pathology|May 1, 1984
Transferrin in disease. I: A potential prognostic indicator in patients undergoing bone marrow transplantationR L Hunter, B Bennett, C Garrison, et al.Leukemia Research|November 1, 1996
The effect of edelfosine on CTP:cholinephosphate cytidylyltransferase activity in leukemic cell linesW R Vogler, M Shoji, D J Hayzer, et al.Cancer|December 1, 1984
Myeloproliferative disorder with profound hypereosinophilia associated with chemotherapy for breast cancerT Soffer, W C Chan, R K Brynes, et al.Lipids|November 1, 1987
Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantationW R Vogler, A C Olson, S Okamoto, et al.Pageof 13